| |
| |
|
| Insider
Information: |
Southwell David P |
| Relationship: |
Chief Executive Office... |
| City: |
Concord |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
224,579 |
|
|
Indirect Shares
|
114,774 |
|
|
| Direct
Value |
$692,169 |
|
|
|
Indirect Value
|
$2,542,569 |
|
|
| Total
Shares |
339,353 |
|
|
| Total
Value |
$3,234,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -22.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2012-07-30 |
0 |
2009-03-13 |
0 |
Premium* |
|
|
First Eagle Alternative Capital ... |
FCRD |
Director |
2010-12-06 |
38,500 |
2010-11-16 |
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-05-08 |
12,850 |
2024-05-08 |
1,650 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
|
2024-05-02 |
1,660 |
2024-05-02 |
113,124 |
Premium* |
|
|
Tscan Therapeutics, Inc. |
TCRX |
Chief Executive Office... |
2022-05-18 |
171,569 |
2021-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRX |
Tscan Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-09-08 |
4 |
B |
$8.73 |
$96,066 |
D/D |
11,000 |
97,899 |
2.81 |
- |
|
| HGSI |
Human Genome Sciences Inc |
David Southwell |
• – – |
2010-06-01 |
4 |
OE |
$2.09 |
$101,731 |
D/D |
17,653 |
90,750 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
President and CEO |
• • – |
2017-01-06 |
4 |
B |
$1.75 |
$105,000 |
D/D |
60,000 |
62,765 |
2.81 |
- |
|
| FCRD |
First Eagle Alternative C... |
Director |
– • – |
2010-11-16 |
4 |
B |
$12.84 |
$110,706 |
D/D |
8,622 |
8,622 |
2.39 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2024-04-15 |
4 |
OE |
$4.34 |
$128,627 |
D/D |
29,624 |
124,784 |
0 |
- |
|
| FCRD |
First Eagle Alternative C... |
Director |
– • – |
2010-11-18 |
4 |
B |
$12.82 |
$146,365 |
D/D |
11,400 |
25,500 |
2.39 |
- |
|
| FCRD |
First Eagle Alternative C... |
Director |
– • – |
2010-12-06 |
4 |
B |
$12.97 |
$157,277 |
D/D |
12,100 |
38,500 |
2.39 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2015-03-23 |
4 |
AS |
$68.99 |
$159,957 |
D/D |
(2,317) |
8,604 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2015-07-06 |
4 |
OE |
$10.85 |
$162,750 |
D/D |
15,000 |
23,604 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-04-17 |
4 |
OE |
$18.01 |
$205,836 |
D/D |
11,429 |
21,929 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2024-04-15 |
4 |
S |
$24.05 |
$240,520 |
D/D |
(10,000) |
114,784 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-03-27 |
4 |
OE |
$27.05 |
$270,500 |
D/D |
10,000 |
20,500 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-10-16 |
4 |
OE |
$10.85 |
$297,510 |
D/D |
27,000 |
13,650 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2024-04-12 |
4 |
OE |
$4.34 |
$303,940 |
D/D |
70,000 |
165,160 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-03-27 |
4 |
AS |
$44.71 |
$450,956 |
D/D |
(10,000) |
10,500 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-04-17 |
4 |
AS |
$50.69 |
$583,187 |
D/D |
(11,429) |
10,500 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2018-12-13 |
4 |
S |
$15.19 |
$588,886 |
D/D |
(38,768) |
95,160 |
0 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2018-12-06 |
4 |
S |
$15.15 |
$800,056 |
D/D |
(52,809) |
138,851 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2015-07-06 |
4 |
AS |
$47.50 |
$1,121,694 |
D/D |
(23,604) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$1,294,399 |
D/D |
(90,835) |
0 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-10-16 |
4 |
AS |
$51.50 |
$1,391,544 |
D/D |
(27,000) |
1,650 |
0 |
% |
|
| RCKT |
Rocket Pharmaceuticals |
|
• • – |
2024-04-12 |
4 |
S |
$24.22 |
$1,705,265 |
D/D |
(70,000) |
95,160 |
0 |
% |
|
47 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
